The role of interleukin 10 in the control of autoimmunity

This publication has 36 references indexed in Scilit:

• Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells
  The Journal of Experimental Medicine, 2002
• In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines
  The Journal of Experimental Medicine, 2002
• Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells
  The Journal of Experimental Medicine, 2002
• Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity
  The Journal of Experimental Medicine, 2000
• DIFFERENTIAL EFFECTS OF EXOGENOUS INTERLEUKIN-10 ON CARDIAC ALLOGRAFT SURVIVAL1,2
  Transplantation, 1999
• IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice [published erratum appears in Int Immunol 1997 Nov;9(11):1773]
  International Immunology, 1997
• IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.
  The Journal of Experimental Medicine, 1996
• Interleukin‐10 prevents experimental allergic encephalomyelitis in rats
  European Journal of Immunology, 1994
• Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic Mouse
  Clinical Immunology and Immunopathology, 1994
• High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
  The Journal of Experimental Medicine, 1994